Gewert D R, Moore G, Tilleray V J, Clemens M J
Eur J Biochem. 1984 Mar 15;139(3):619-25. doi: 10.1111/j.1432-1033.1984.tb08049.x.
Treatment of Daudi cells with human lymphoblastoid interferons for up to 5 days progressively inhibits cell proliferation. For the first 3 days cells continue to grow but with prolonged doubling times; subsequently, net proliferation ceases and is accompanied by a loss of cell viability. We have investigated the changes in labelling of DNA with radioactive precursors which occur during the first phase of the response to interferon treatment. We have shown previously [Gewert et al. (1981) Eur. J. Biochem. 116, 487-492] that inhibition of incorporation of [3H]thymidine into DNA can be accounted for by impairment of thymidine transport and thymidine kinase activity. In spite of this inhibition, the total intracellular dTTP pool is larger in interferon-treated than in control cells. Because of these changes it has been necessary to use other methods to determine whether interferon treatment inhibits the overall rate of DNA synthesis. The results of experiments employing (a) moderately high thymidine concentrations or (b) incorporation of radioactivity from deoxynucleoside triphosphates into DNA in detergent-lysed or permeabilised cell systems indicate that there is in fact relatively little inhibition of the overall rate of DNA synthesis in cells exposed to up to 100 units/ml of interferons for at least 48 h. Furthermore, a similar proportion of cells incorporate [3H]thymidine in control and interferon-treated cultures and there is only a small decrease in the number of cells in S phase after interferon treatment, as revealed by fluorescence-activated cell sorting. These results indicate that cell proliferation may be regulated in this system by a mechanism in which there is a loss of coordination between the initiation of DNA synthesis and the subsequent events required for cell division.
用人淋巴母细胞干扰素处理Daudi细胞长达5天会逐渐抑制细胞增殖。在最初3天,细胞继续生长,但倍增时间延长;随后,净增殖停止并伴有细胞活力丧失。我们研究了在干扰素处理反应的第一阶段,用放射性前体标记DNA时发生的变化。我们之前已经表明[Gewert等人(1981年),《欧洲生物化学杂志》116卷,487 - 492页],[3H]胸苷掺入DNA的抑制可归因于胸苷转运和胸苷激酶活性受损。尽管有这种抑制作用,但干扰素处理的细胞中细胞内总的dTTP池比对照细胞中的更大。由于这些变化,有必要使用其他方法来确定干扰素处理是否抑制DNA合成的总体速率。采用(a)适度高的胸苷浓度或(b)在去污剂裂解或通透化的细胞系统中将脱氧核苷三磷酸的放射性掺入DNA的实验结果表明,实际上暴露于高达100单位/毫升干扰素至少48小时的细胞中,DNA合成的总体速率受到的抑制相对较小。此外,对照培养物和干扰素处理培养物中掺入[3H]胸苷的细胞比例相似,并且如荧光激活细胞分选所显示的,干扰素处理后S期细胞数量仅略有减少。这些结果表明,在这个系统中细胞增殖可能受一种机制调节,在该机制中DNA合成的起始与细胞分裂所需的后续事件之间失去了协调。